Tether Invests $200 Million in Blackrock Neurotech, Revolutionizing Healthcare with Brain-Computer Interface Technology

Tether, a leading stablecoin issuer, has invested $200 million in Blackrock Neurotech, a pioneer in brain-computer interface (BCI) technology, positioning Tether as the majority shareholder and bolstering Blackrock Neurotech's commercialization and research initiatives. This investment marks Tether's expansion beyond its stablecoin operations through its venture division, Tether Evo, and signals a focus on projects that merge technological advancements with human potential.

Tether Invests $200 Million in Blackrock Neurotech, Revolutionizing Healthcare with Brain-Computer Interface Technology

New York, April 29, 2024 - Stablecoin behemoth Tether has made a groundbreaking investment of $200 million in Blackrock Neurotech, a biotech firm pioneering brain-computer interface (BCI) technology. This strategic move positions Tether as the majority stakeholder in Blackrock Neurotech, propelling the company's mission to commercialize its innovative medical tools and accelerate research and development.

The investment builds on Tether's remarkable financial performance, having reported a record net profit of $2.9 billion in the fourth quarter of 2023. This underscores Tether's unwavering commitment to investing in transformative technologies that empower human potential.

"Blackrock Neurotech is just the beginning of our ambitious journey through Tether Evo, where we venture into projects that redefine the boundaries of technological innovation and human potential," exclaimed Paolo Ardoino, Tether's Chief Technology Officer. He emphasized that Blackrock Neurotech's groundbreaking technology holds immense promise for enhancing communication, rehabilitation, and cognitive functions.

Founded in 2008, Blackrock Neurotech has emerged as a global leader in BCI technology. Its innovative solutions empower individuals with paralysis and neurological disorders to control devices solely through their thoughts. In a groundbreaking moment, Nathan Copeland utilized Blackrock Neurotech's technology to interact with former U.S. President Barack Obama in 2016.

Dr. Florian Solzbacher, co-founder of Blackrock Neurotech, hailed the partnership with Tether as a pivotal step in advancing healthcare technologies: "Tether's investment is a testament to the power of collaboration between finance and science. This alliance will accelerate our mission to bring BCI solutions to those in need."

Tether's investment in Blackrock Neurotech is part of its strategic expansion beyond stablecoins. The company has established additional divisions, including Tether Data, Tether Finance, Tether Power, and Tether Education, firmly establishing its position as an innovator at the intersection of technology and human potential.

"Our investment in Blackrock Neurotech is a testament to our belief in the transformative power of BCI technology to improve lives," asserted Paolo Ardoino. "We are honored to support Blackrock Neurotech's vision of a future where humans and machines seamlessly collaborate, unlocking new possibilities for healthcare and beyond."

This strategic investment aligns with Tether's broader commitment to advancing financial inclusion and innovation. By empowering transformative projects like Blackrock Neurotech, Tether continues to drive progress at the forefront of technology, paving the way for a future where human potential is amplified by groundbreaking advancements.